Robert W. Baird Analysts Give LifePoint Health, Inc. (LPNT) a $55.00 Price Target

LifePoint Health, Inc. (NASDAQ:LPNT) has been given a $55.00 price target by equities research analysts at Robert W. Baird in a note issued to investors on Monday. The brokerage currently has a “buy” rating on the stock. Robert W. Baird’s target price points to a potential upside of 11.62% from the stock’s current price.

Other equities research analysts have also issued research reports about the company. Royal Bank Of Canada restated a “buy” rating and set a $77.00 price objective on shares of LifePoint Health in a research note on Wednesday, July 5th. Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 target price for the company in a research report on Tuesday, July 4th. ValuEngine upgraded LifePoint Health from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. TheStreet lowered LifePoint Health from a “b-” rating to a “c+” rating in a research report on Wednesday, August 16th. Finally, BidaskClub lowered LifePoint Health from a “buy” rating to a “hold” rating in a research report on Saturday, July 8th. Three research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $63.54.

Shares of LifePoint Health (NASDAQ:LPNT) traded down 1.98% during trading on Monday, reaching $48.30. The company had a trading volume of 399,960 shares. The firm has a 50-day moving average price of $56.48 and a 200-day moving average price of $60.50. LifePoint Health has a 52-week low of $47.00 and a 52-week high of $70.95. The company has a market capitalization of $1.94 billion, a P/E ratio of 10.82 and a beta of 0.84.

LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings data on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.15). LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.60 billion. During the same quarter last year, the business earned $0.94 EPS. LifePoint Health’s revenue for the quarter was down .7% compared to the same quarter last year. On average, analysts predict that LifePoint Health will post $4.07 EPS for the current fiscal year.

LifePoint Health declared that its board has initiated a share buyback plan on Friday, October 27th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: “Robert W. Baird Analysts Give LifePoint Health, Inc. (LPNT) a $55.00 Price Target” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://www.com-unik.info/2017/10/30/robert-w-baird-reaffirms-outperform-rating-for-lifepoint-health-inc-lpnt.html.

A number of large investors have recently added to or reduced their stakes in LPNT. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in LifePoint Health by 10.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after purchasing an additional 164 shares during the period. LS Investment Advisors LLC boosted its position in LifePoint Health by 43.7% during the 2nd quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock valued at $120,000 after purchasing an additional 543 shares during the period. US Bancorp DE boosted its position in LifePoint Health by 0.8% during the 2nd quarter. US Bancorp DE now owns 1,947 shares of the company’s stock valued at $130,000 after purchasing an additional 16 shares during the period. Shelton Capital Management acquired a new position in LifePoint Health during the 2nd quarter valued at approximately $205,000. Finally, Teacher Retirement System of Texas boosted its position in LifePoint Health by 0.3% during the 2nd quarter. Teacher Retirement System of Texas now owns 3,211 shares of the company’s stock valued at $216,000 after purchasing an additional 9 shares during the period. Institutional investors and hedge funds own 99.53% of the company’s stock.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

What are top analysts saying about LifePoint Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LifePoint Health Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit